A case of sarcoidosis of the paranasal sinuses is reported. Biopsies of the sinus mucosa showed typical noncaseating granulomas. Hydroxychloroquine, which is known to be active on the cutaneous form of sarcoidosis, was used here with success and is proposed as an effective alternative to high-dose systemic steroids.
The aetiology of sarcoidosis, which was first described by Besnier showed persistence of hilar lymph node enlargement. During three years of follow-up the patient did not receive any specific treatment and did not relapse.
In November 1994 he presented with new episodes of recurrent sinusitis. Biopsies performed in the right maxillary sinus demonstrated a recurrence of sarcoidosis in this area. The patient received a second trial of hydroxychloroquine (200 mg orally once a day) for five months with a similar favourable response (negative biopsies after five months). Hydroxychloroquine was discontinued and he is still (June 1997) free of symptoms.
Discussion
In the large series reported by McCaffrey and McDonald,5 8 head and neck involvement were demonstrated in 9% of cases of sarcoidosis. When present, the affected sites included lacrimal glands (40%), skin (26%), nose (13%), central and peripheral nervous system (6%), larynx (6%), salivary glands (4%), cervical lymph nodes (4%), and the middle ear (1%). According to these authors, nose and paranasal sinus involvement occurs in about 1% of patients. Other authors have described abnormal sinus X-rays with thickening of the mucosa attributed to sarcoidosis but this was not always proved by biopsy.8-" Recently, Krespi et al"3 have proposed a staging system for sarcoidosis of the sinonasal tract. According to these authors, our case is a stage III because of multiple sinus involvement and should be treated by systemic corticosteroids.
Differential diagnosis of the granulomatous diseases occurring in the upper respiratory tract includes tuberculosis, leprosy, syphilis, Wegener's granulomatosis and sarcoidosis.1 " All these aetiologies other than sarcoidosis were excluded in this reported case. When the diagnosis of sarcoidosis is suspected, based on the patient's history, biopsy should be performed prior to surgery. We think that, in this case, the functional endonasal sinus surgery performed in the other hospital was not helpful.
Corticosteroids are the most effective drugs in the treatment of sarcoidosis. Usually, 20-40 mg of prednisolone are given daily for three to six months. Other drugs such as chloroquine or hydroxychloroquine, azathioprine, and methotrexate, have been used, with varying success.' "4 15 To our knowledge, this is the first reported case of sarcoidosis of the paranasal sinus to be successfully treated with hydroxychloroquine.
This treatment led to the cure of the sinus involvement, but not of the mediastinal lymph node involvement or pulmonary sarcoidosis. As the patient only complained of sinusitis, this treatment was thus appropriate. The response to the second trial of hydroxychloroquine strengthens the evidence of its efficacy in this indication. Following this observation, we suggest that upper respiratory tract mucosal sarcoidosis can be successfully treated with hydroxychloroquine which was until now considered to be active mainly on the cutan eous forms of sarcoidosis. Hydroxychloroquine is extensively used for its immunosuppressive effects in various autoimmune disorders. Ocular toxicity (keratopathy, retinopathy) is unlikely to occur at the 'low' daily dosage used here (200-400 mg/day), even on long-term therapy (more than six months) when regular ocular testing is performed. '6 17 
